The utility of SARS‐CoV‐2‐specific serology in COVID‐19 diagnosis

INTRODUCTION: In May 2020, The Communicable Diseases Network of Australia (CDNA) case definition introduced serological criteria to support the diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). We present findings that support the utility of SARS‐CoV‐2‐specific serology for...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasan, Tasnim, Lim, H. Ling, Case, Jennifer, Hueston, Linda, Bag, Shopna, Dwyer, Dominic E., O'Sullivan, Matthew V.N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Covid‐19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652559/
https://www.ncbi.nlm.nih.gov/pubmed/34761846
http://dx.doi.org/10.1111/1753-6405.13155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652559/
https://www.ncbi.nlm.nih.gov/pubmed/34761846
http://dx.doi.org/10.1111/1753-6405.13155

Ejemplares similares